Transcriptional Analysis Reveals Evidence of Chronically Impeded ECM Turnover and Epithelium-to-Mesenchyme Transition in Scar Tissue Giving Rise to Marjolin's Ulcer

J Burn Care Res. 2017 Jan/Feb;38(1):e14-e22. doi: 10.1097/BCR.0000000000000432.

Abstract

Marjolin's ulcer (MU) is an aggressive malignancy arising within chronic wounds. A major cause is unhealed burn injuries. This results in well-differentiated squamous cell carcinoma (SCC). This study aimed to elucidate transcriptional changes leading to malignancy by investigating differentially expressed genes in squamous cells present in a SCC compared with MU. MU tumor cells were isolated from histologically confirmed biopsy of SCC within an unhealed burn scar. Epithelial cells (ECs) adjacent to the tumor were co-isolated and a SCC cell line was commercially purchased. mRNA from all three samples was isolated and its expression was quantified using RNASeq. A threshold of log2fold change >2-fold in either direction was considered "differentially expressed." Gene expression analysis revealed distinct differences in gene expression in MU cells compared with EC (665 genes), EC and SCC (1673 genes). Enrichment analysis confirmed that pathways most affected included 1) elevation of genes associated with extracellular matrix organization/degradation, 2) activation of DNA damage, and 3) activation of cytokine signaling. Our analysis revealed two key insights about chronic wound microenvironment conducive to ulceration. First, in EC vs. MU comparison, downregulation of Collagen and Matrix metalloproteinase families suggests chronically impaired extracellular matrix turnover giving rise to a fibrotic microenvironment. Second, in SCC vs. MU comparison, dysregulation of cadherin-mediated cell-cell adhesions is suggestive of epithelial-to-mesenchymal transitions, similar to those during development. Acquisition of epithelial-to-mesenchymal transition may underlie the high metastatic rate in MU tumors. Taken together, this sheds light on mechanisms that underlie the divergent clinical features of these cutaneous cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy, Needle
  • Burns / complications
  • Burns / pathology
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / pathology*
  • Cell Transformation, Neoplastic / pathology*
  • Cells, Cultured
  • Chronic Disease
  • Cicatrix / genetics
  • Cicatrix / pathology
  • Gene Expression Regulation
  • Humans
  • Immunohistochemistry
  • RNA, Messenger / genetics*
  • Reference Values
  • Sequence Analysis, RNA
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology*
  • Skin Ulcer / etiology
  • Skin Ulcer / genetics*
  • Skin Ulcer / pathology*
  • Transcriptional Activation

Substances

  • RNA, Messenger